1F/D2 Limb-girdle Muscular Dystrophy researchers share their advances

From Conquimando Escalones and with a custom that has been maintained since the pandemic, we have promoted a new meeting, which in a virtual way, has brought together all the research groups involved in the research for the cure of Limb-girdle Muscular Dystrophy 1F/D2 . With our sights set on finally being able to organize an appointment in person again in the final stretch of this year, once again, it has been exciting to see first-hand the progress and joint work between the different institutes and laboratories. In addition, as we always say, these periodic virtual meetings are a great tool to be able to work more quickly and effectively towards the goal of new treatments.

Among other things, in the session held at the beginning of this month of June we have been able to learn more about the drugs that already work in the laboratory and that are just being tested in animal models. For example, the tests at different doses have been discussed to see which one will be the highest safe in humans and it has already been sent to a toxicology report, these being hopeful steps for a clinical trial in humans that is getting closer and closer. Also the fruits of the work of the acquired antibody or the transcriptome of our muscle samples carried out months ago. And as a result of all the work of these months, more hypotheses and lines appear that will continue to be deepened in the coming months.

As we always remember, there is work ahead and our work is hard and complicated, but we will continue to work hard so that, hopefully soon, there will be a cure for many. We are proud to be able to unite world-class researchers and we are very grateful for all their work and generosity.